7.4 Plasma and recombinant products supplied under contract in 2007–08

List of products supplied under the Plasma Products Agreement
Supplier Product
type/trade name		 Clinical use approved under the
National Blood Arrangements
CSL Limited Albumin
Albumex 4 Used to treat hypovolaemia arising from shock, surgery or multiple organ failure
Albumex 20 Used to treat patients suffering extensive burns or shock due to blood loss, or kidney or liver disease
Immunoglobulins
Hyper immune globulins Used to prevent a specific infection such as tetanus, hepatitis B, Zoster or cytomegalovirus
Intragam P Used to reduce susceptibility to infections and manage many immune system disorders
Rh (D) Used to prevent a potentially fatal form of anaemia in newborn babies of Rh (D) negative mothers
Clotting factors
Biostate Used to treat Factor VII deficiency, known as haemophilia A
MonoFIX-VF Used to treat patients who have Factor IX deficiency, known as haemophilia B or Christmas disease
Prothrombinex-VF Used to manage some bleeding disorders (concentrated clotting factors) and warfarin reversal
Thrombotrol-VF Used to manage an inherited condition wherein a patient’s blood clots too quickly

 

List of imported IVIg products
Supplier Product
type/trade name		 Clinical use approved under the
National Blood Arrangements
CSL Limited Sandoglobulin Used to reduce susceptibility to infections and manage many immune system disorders
Octapharma Australia Pty Ltd Octagam Used to reduce susceptibility to infections and manage many immune system disorders

 

List of imported rare bleeding and blood disorder plasma products
Supplier Product
type/trade name		 Clinical use approved under the
National Blood Arrangements
Baxter Healthcare Pty Ltd Anti Inhibitor Coagulant Complex Concentrates/FEIBA Used to treat bleeding episodes including surgical interventions in haemophilia A and B patients with inhibitors
Baxter Healthcare Pty Ltd Protein C/Ceprotin Used to treat congenital Protein C deficiency
Baxter Healthcare Pty Ltd FVII concentrate Used to treat Factor VII deficiency
CSL Limited FXI/BPL Factor XI

LFB Hemoleven

 Used to treat people with Factor XI deficiency (sometimes called haemophilia C)
CSL Limited FXIII/Fibrogammin P Used to treat people with Factor XIII deficiency
CSL Limited Rh (D) Immunoglobulin/WinRho Used to prevent haemolytic disease of the newborn (HDNB), a potentially fatal form of anaemia in newborn babies of Rh (D) negative mothers

 

List of imported rare bleeding and blood disorder recombinant products
Supplier Product
type/trade name		 Clinical use approved under the
National Blood Arrangements
Novo Nordisk Pharmaceuticals Pty Ltd rFVIIa/NovoSeven Used to treat bleeding episodes including surgical intervention in haemophilia A or B patients with inhibitors to Factor VIII or Factor IX; also used to treat complex bleeding episodes in surgery, trauma and septicaemia
Baxter Healthcare Pty Ltd rFVIII/Recombinate Used to treat Factor VIII deficiency, known as haemophilia A
Baxter Healthcare Pty Ltd rFVIII/Advate Used to treat Factor VIII deficiency, known as haemophilia A
Wyeth Australia Pty Ltd rFVIII/Refacto Used to treat Factor VIII deficiency, known as haemophilia A
Wyeth Australia Pty Ltd rFIX/BeneFIX Used to treat patients who have Factor IX deficiency, known as haemophilia B or Christmas disease

Back to top

< Previous | Contents | Next >